Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review
Related Experiment Video
Updated: Aug 19, 2026

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Matthieu Béreau1, Vanessa Fleury2, Walid Bouthour2
1Service de neurologie, université de Franche-Comté, CHRU de Besançon, 25030 Besançon, France; Unité extrapyramidale, département des neurosciences cliniques, HUG, faculté de médecine, université de Genève, 1205 Genève, Suisse.
Abstract:
Impulse control disorders (ICDs) and other related behaviors, such as punding and dopamine dysregulation syndrome, are frequent yet underrecognized non-motor complications of dopamine replacement therapy (DRT) in Parkinson's disease (PD); they can also have a major negative impact on quality of life. They result from complex interactions between a given individual's predispositions, non-physiological dopaminergic stimulation and PD pathology. Also, sensitization of the mesocorticolimbic pathway, reflected by the psychotropic effects of dopaminergic treatment, plays a crucial role in the emergence of these addictive behaviors. While early detection of changes in behavior, less use of dopamine agonists (DA) that have a relative selectivity for mesocorticolimbic dopamine receptors, and fractionation of levodopa dosages to avoid non-physiological pulsatile stimulation of dopamine receptors are key strategies in the management of this hyperdopaminergic behavioral spectrum, other complementary approaches are also addressed in this review.
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll

